相关实验视频
Updated: Jun 4, 2025
07:30
Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
3.4K
通过脏配对捐赠推动活体捐赠的边界
Abhishek Kumar1, Angie G Nishio Lucar2, Mona D Doshi3
1Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
概括
结合捐献 (KPD) 通过克服不兼容性和降低成本,增加了活体捐献者移植 (LDKT). 然而,有限的参与和可变的捐赠者保护强调了需要采取国家行动,以确保公平获得LDKT.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植 移植 移植 移植
- 器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器
背景情况:
- 活体捐赠者移植 (LDKT) 是末期病的首选治疗方法.
- 配对捐献 (KPD) 已经超越了免疫学障碍,以解决其他不相容性和财务阻碍.
- 据了解,KPD为大量的LDKT提供便利,在2021年完成的LDKT比例为18.6%.
研究的目的:
- 审查KPD计划的演变和当前景观.
- 探索加强KPD参与和可访问性的策略.
- 倡导国家监管监督和活体脏捐献的财政中立性.
主要方法:
- 审查KPD程序结构和参与率.
- 在移植中心对KPD可用性差异的分析.
- 检查私人KPD计划提供的捐赠者保护.
主要成果:
- 私人拥有的KPD计划很普遍,但参与并不普遍,40%的中心不提供KPD.
- 在KPD可用性方面存在地理差异,可能会限制LDKT的机会.
- 活着的捐赠者获得财务和法律保护的机会是可变的,并非普遍可用的.
结论:
- 加强KPD参与对于最大限度地提高LDKT率至关重要.
- 对于捐赠者和接受者候选人来说,需要提高有关活体捐赠选择的透明度.
- 需要采取国家行动来规范监管监督,并确保所有活着的脏捐赠者的财务中立性.
相关概念视频
01:24Tissue Transplantation
338
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
338
01:22Bone Marrow Sampling and Transplants
282
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
282